glp 1 drugs and ms Emerging research suggests that GLP-1 medications like Ozempic Wegovy might be beneficial for people with MS. Researchers are exploring how maintaining a healthy weight impacts symptoms and how like Chart: 1 in 8 Americans

The use of semaglutide was associated with improved clinical symptoms, physical activity, exercise function, quality of life, and more significant weight loss than the placebo group

Keywords: Glucagon-like peptide-1 agonists, Osteoarthritis, Rheumatoid arthritis, Psoriatic arthritis, System lupus erythematosus, Inflammation Core Tip: Growing evidence suggests that glucagon-like peptide-1 and its receptor agonists could be an effective treatment option not only for metabolic disorders but also for a range of autoimmune and inflammatory diseases

As previously mentioned, patients with T2D on incretin-based therapies showed significant weight loss and improved glycemic control with little experience of hypoglycemia (47)

Again, we encourage you to call our helpline to discuss your coverage options